<SUBMISSION>
<ACCESSION-NUMBER>0000950134-09-002973
<TYPE>8-K
<PUBLIC-DOCUMENT-COUNT>3
<PERIOD>20090217
<ITEMS>2.02
<ITEMS>9.01
<FILING-DATE>20090217
<DATE-OF-FILING-DATE-CHANGE>20090217
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>MANNKIND CORP
<CIK>0000899460
<ASSIGNED-SIC>2834
<IRS-NUMBER>133607736
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>8-K
<ACT>34
<FILE-NUMBER>000-50865
<FILM-NUMBER>09607315
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>28903 NORTH AVE PAINE
<CITY>VALENCIA
<STATE>CA
<ZIP>91355
<PHONE>6617755300
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>28903 NORTH AVE PAINE
<CITY>VALENCIA
<STATE>CA
<ZIP>91355
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>v51492e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>e8vk</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>




<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>WASHINGTON, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT</B>
</DIV>


<DIV align="center" style="font-size: 12pt; margin-top: 0pt"><B>Pursuant to Section&nbsp;13 or 15(d) of the<BR>
Securities Exchange Act of 1934</B>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date of Report (Date of earliest event reported): February&nbsp;17, 2009</B></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>MannKind Corporation</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>Delaware</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>000-50865</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>13-3607736</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(State or other jurisdiction of
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Commission File Number)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(IRS Employer</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">incorporation)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="47%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="47%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD align="center" valign="top"><B>28903 North Avenue Paine</B></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top"><B>Valencia, California</B>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top"><B>91355</B></TD>
</TR>
<TR valign="bottom">
    <TD align="center" valign="top">(Address of principal executive offices)
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Registrant&#146;s Telephone Number, Including Area Code: <B>(661)&nbsp;775-5300</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>N/A</B><BR>
(Former name or former address, if changed since last report)</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions (<I>see </I>General Instruction
A.2. below):
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17
CFR 240.14d-2(b))</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="1%" nowrap align="left"><FONT face="Wingdings">&#111;</FONT></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17
CFR 240.13e-4(c))</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>





<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV style="margin-top: 6pt"><TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">



</TABLE>
</DIV>

<!--TOC-->
<!--/TOC-->




<!-- link1 "Item&nbsp;2.02 Results of Operations and Financial Condition" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;2.02 Results of Operations and Financial Condition</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">On February&nbsp;17, 2009, MannKind Corporation issued a press release announcing its financial results
for the fourth quarter and full year 2008. A copy of the press release is attached as Exhibit&nbsp;99.1
to this Current Report and is incorporated herein by reference.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The information in this Current Report is being furnished and shall not be deemed &#147;filed&#148; for the
purposes of Section&nbsp;18 of the Securities and Exchange Act of 1934, as amended, or otherwise subject
to the liabilities of that Section. The information in this Current Report shall not be
incorporated by reference into any registration statement or other document pursuant to the
Securities Act of 1933, as amended.
</DIV>

<!-- link1 "Item&nbsp;9.01 Financial Statements and Exhibits" -->

<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">(c)&nbsp;Exhibits. The following exhibit is furnished herewith:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="97%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release of MannKind Corporation dated February&nbsp;17, 2009,
reporting MannKind&#146;s financial results for the fourth quarter and
full year 2008.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<!-- link1 "SIGNATURE" -->

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SIGNATURE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="45%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="40%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><B>MANNKIND CORPORATION</B></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">By:</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">/s/ <FONT style="font-variant: SMALL-CAPS">matthew j. pfeffer</FONT></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Name:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Matthew J. Pfeffer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Title:
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Corporate Vice President and Chief</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Financial Officer</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Dated: February&nbsp;17, 2009
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">
<!-- link1 "EXHIBIT INDEX" -->

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXHIBIT INDEX</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="97%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD nowrap align="left">Number</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">Description</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">99.1
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Press Release of MannKind Corporation dated February&nbsp;17, 2009, reporting
MannKind&#146;s financial results for the fourth quarter and full year 2008.</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>v51492exv99w1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>exv99w1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="right" style="font-size: 10pt; margin-top: 12pt">Exhibit&nbsp;99.1
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt"><IMG src="v51492v5149200.gif" alt="(MANNKIND CORPORATION LOGO)">
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 6pt"><U><B>Company Contact:</B></U><BR>
Matthew J. Pfeffer<BR>
Corporate Vice President and<BR>
Chief Financial Officer<BR>
661-775-5300<BR>
mpfeffer@mannkindcorp.com

</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>MANNKIND CORPORATION REPORTS FOURTH QUARTER AND FULL<BR>
YEAR 2008 FINANCIAL RESULTS</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>- Conference Call to Begin Today at 4:00 PM ET -</B>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>VALENCIA, Calif., February&nbsp;17 /PRNewswire-FirstCall/ &#151; MannKind Corporation (Nasdaq: MNKD) </B>today
reported financial results for the fourth quarter and year ended December&nbsp;31, 2008.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">For the fourth quarter of 2008, total operating expenses were $81.8&nbsp;million, compared to $79.1
million for the fourth quarter of 2007. Research and development (R&#038;D) expenses increased by $2.0
million to $68.8&nbsp;million for the fourth quarter of 2008 compared to the fourth quarter of 2007.
This increase is primarily due to higher manufacturing costs (including clinical supplies) for
AFRESA<SUP style="font-size: 85%; vertical-align: text-top">&#174;</SUP>, offset in part by lower purchased services in the associated clinical development program,
and lower technology agreement costs in our oncology research programs. General and administrative
(G&#038;A) expenses increased by $0.7&nbsp;million to $13.0&nbsp;million for the fourth quarter of 2008 compared
to the fourth quarter of 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The net loss applicable to common stockholders for the fourth quarter of 2008 was $83.3&nbsp;million, or
$0.82 per share based on 101.8&nbsp;million weighted average shares outstanding, compared with a net
loss applicable to common stockholders of $75.0&nbsp;million, or $0.75 per share based on 99.6&nbsp;million
weighted average shares outstanding, for the fourth quarter of 2007.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">For the year ended December&nbsp;31, 2008, total operating expenses were $305.8&nbsp;million, compared with
$307.4&nbsp;million for 2007. R&#038;D expenses were $250.4&nbsp;million in 2008, down $6.4&nbsp;million from 2007,
primarily related to lower technology agreement costs in our oncology research programs and
decreased clinical development program expenses, which were offset by increases in manufacturing
costs (including clinical supplies) for
</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">AFRESA and associated clinical development program expenses. G&#038;A expenses increased by $4.8&nbsp;million
to $55.3&nbsp;million for 2008 as compared to 2007 primarily due to salaries and stock compensation
expenses. The total number of employees decreased from 609 at the end of 2007 to 580 at the end of
2008.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The net loss applicable to common stockholders for 2008 was $303.0&nbsp;million, or $2.98 per share
based on 101.6&nbsp;million weighted average shares outstanding, compared with a net loss applicable to
common stockholders of $293.2&nbsp;million, or $3.66 per share based on 80.0&nbsp;million weighted averages
shares outstanding for 2007. The number of common shares outstanding at December&nbsp;31, 2008 was
102,008,096.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Cash, cash equivalents and marketable securities were $46.5&nbsp;million at December&nbsp;31, 2008, $95.2
million at September&nbsp;30, 2008, and $368.3&nbsp;million at December&nbsp;31, 2007. Currently, the Company has
additional financial resources of $320.0&nbsp;million available under the loan arrangement with our
principal stockholder.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">&#147;Our NDA for AFRESA is now almost finished,&#148; stated Alfred Mann, Chairman and Chief Executive
Officer. &#147;Little more than the hyperlinking of the electronic submission remains to be completed.
Our clinical, regulatory and CMC teams have done an extraordinary job assembling a comprehensive
document that describes the robust safety and efficacy data that we have collected for AFRESA. The
extensive clinical program that we conducted has provided evidence that AFRESA consistently
decreases A1C levels and additionally offers marked benefits for patients in terms of post-prandial
glucose control, fasting glucose control, weight loss and hypoglycemia. Moreover, the studies
indicate that AFRESA achieves these clinical benefits without any adverse effects on pulmonary
function. We look forward to the year ahead as we transition from the development of AFRESA into
commercial readiness.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Conference Call
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">MannKind management will host a conference call to discuss these results today at 4:00 PM ET. To
participate in the call, please dial (888)&nbsp;677-5721 or (210)&nbsp;839-8507. To listen to the call via
the internet, please visit http://www.mannkindcorp.com. The web site replay will be available for
14&nbsp;days. A telephone replay will be accessible for approximately 14&nbsp;days following completion of
the call by dialing (800)&nbsp;756-2759 or (402)&nbsp;998-0791.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Presenting from the Company will be:
</DIV>


<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Chairman and Chief Executive Officer Alfred Mann</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>President and Chief Operating Officer Hakan Edstrom</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Corporate Vice President and Chief Financial Officer Matthew Pfeffer</TD>
</TR>

<TR>
    <TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
    <TD width="2%" style="background: transparent">&nbsp;</TD>
    <TD width="3%" nowrap align="left"><B>&#149;</B></TD>
    <TD width="1%">&nbsp;</TD>
    <TD>Corporate Vice President and Chief Scientific Officer Peter Richardson</TD>
</TR>

</TABLE>
</DIV>
<DIV align="left" style="font-size: 10pt; margin-top: 10pt">About MannKind Corporation
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">MannKind Corporation (Nasdaq: MNKD) focuses on the discovery, development and commercialization of
therapeutic products for patients with diseases such as diabetes and
</DIV>
<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">cancer. Its pipeline includes AFRESA, which has completed Phase 3 clinical trials, and MKC253,
which is currently in Phase 1 clinical trials. Both of these investigational products are being
evaluated for their safety and efficacy in the treatment of diabetes. MannKind maintains a website
at <u>http://www.mannkindcorp.com</u> to which MannKind regularly posts copies of its press release as
well as additional information about MannKind. Interested persons can subscribe on the MannKind
website to email alerts that are sent automatically when MannKind issues press releases, files its
reports with the SEC or posts certain other information to the website.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 12pt">Forward-Looking Statements
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">This press release contains forward-looking statements, including statements related to
differentiating AFRESA from other insulins. Words such as &#147;believes,&#148; &#147;anticipates,&#148; &#147;plans,&#148;
&#147;expects,&#148; &#147;intend,&#148; &#147;will,&#148; &#147;goal,&#148; &#147;potential&#148; and similar expressions are intended to identify
forward-looking statements. These forward-looking statements are based upon MannKind&#146;s current
expectations and involve risks and uncertainties. Actual results and the timing of events could
differ materially from those anticipated in such forward-looking statements as a result of these
risks and uncertainties, which include, without limitation, risks related to the progress, timing
and results of clinical trials, difficulties or delays in seeking or obtaining regulatory approval,
and other risks detailed in MannKind&#146;s filings with the Securities and Exchange Commission,
including the Annual Report on Form 10-K for the year ended December&nbsp;31, 2007 and periodic reports
on Form 10-Q and Form 8-K. You are cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release. All forward-looking statements
are qualified in their entirety by this cautionary statement, and MannKind undertakes no obligation
to revise or update any forward-looking statements to reflect events or circumstances after the
date of this press release.
</DIV>


<DIV align="Center" style="font-size: 10pt; margin-top: 6pt">(Tables to follow)

</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>MannKind Corporation<BR>
(A Development Stage Company)<BR>
Condensed Statements of Operations<BR>
(Unaudited)</B><BR>
(In thousands, except per share amounts)
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>Cumulative</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>period from</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>February 14,</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>1991 (date of</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Three months ended</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6"><B>Twelve months ended</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>inception) to</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000"><B>December 31,</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="6" style="border-bottom: 1px solid #000000"><B>December 31,</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2"><B>December 31,</B></TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>2008</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>2007</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>2008</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>2007</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>2008</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Revenue</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">20</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">10</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">2,988</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Operating expenses:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Research and development</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">68,777</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">66,751</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">250,442</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">256,844</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">997,482</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">General and administrative</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,978</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">12,316</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">55,343</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">50,523</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">245,842</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">In-process research and development
costs</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">19,726</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Goodwill impairment</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">151,428</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Total operating expenses</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">81,755</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">79,067</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">305,785</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">307,367</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,414,478</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Loss from operations</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(81,755</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(79,067</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(305,765</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(307,357</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(1,411,490</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other expense</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(55</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(355</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(62</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(197</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(1,943</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Interest expense on note payable to
principal stockholder</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(12</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(12</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(1,523</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Interest expense on senior convertible
notes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(1,742</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(584</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(2,327</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(3,408</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(5,957</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Interest income</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">271</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">4,996</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,129</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">17,775</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">36,861</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Loss before provision for income taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(83,293</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(75,010</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(303,037</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(293,187</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(1,384,052</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Income taxes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(2</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(3</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(2</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(3</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(26</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net loss</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(83,295</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(75,013</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(303,039</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(293,190</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(1,384,078</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Deemed dividend related to beneficial
conversion feature of convertible
preferred stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(22,260</TD>
    <TD nowrap>)</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Accretion on redeemable preferred stock</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">&nbsp;</TD>
    <TD align="right">(952</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net loss applicable to common
stockholders</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(83,295</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(75,013</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(303,039</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(293,190</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(1,407,290</TD>
    <TD nowrap>)</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Net loss per share applicable to
common stockholders &#151; basic and
diluted</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(0.82</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(0.75</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(2.98</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left">$</TD>
    <TD align="right">(3.66</TD>
    <TD nowrap>)</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Shares used to compute basic and
diluted net loss per share applicable
to common stockholders</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">101,758</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">99,605</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">101,561</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">80,038</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>


<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif">


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>MannKind Corporation<BR>
(A Development Stage Company)<BR>
Condensed Balance Sheet<BR>
(Unaudited)</B><BR>
(in thousands)
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
    <TD width="76%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
</TR>
<TR style="font-size: 8pt" valign="bottom">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>December 31, 2008</B></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="center" colspan="2" style="border-bottom: 1px solid #000000"><B>December 31, 2007</B></TD>
    <TD>&nbsp;</TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Assets</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Current assets:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Cash and cash equivalents</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">27,648</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">368,285</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Marketable securities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">18,844</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:45px; text-indent:-15px">State research and development credit exchange receivable &#151; current</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">831</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:45px; text-indent:-15px">Prepaid expenses and other current assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">5,983</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">9,596</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total current assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">53,975</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">378,712</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Property and equipment &#151; net</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">226,436</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">162,683</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">State research and development credit exchange receivable &#151; net of current portion</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,500</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">1,500</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Other assets</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">548</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">548</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:30px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">282,459</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">543,443</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px"><B>Liabilities and Stockholders&#146; Equity</B></DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Current liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">53,472</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">67,558</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Senior convertible notes</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">112,253</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">111,761</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Note payable to principal stockholder</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">30,000</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Other liabilities</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">&#151;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">24</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom" style="background: #cceeff">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Stockholders&#146; equity</DIV></TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">86,734</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right">364,100</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD nowrap colspan="2" align="right" style="border-top: 1px solid #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD><DIV style="margin-left:15px; text-indent:-15px">Total</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">282,459</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left">$</TD>
    <TD align="right">543,443</TD>
    <TD>&nbsp;</TD>
</TR>
<TR style="font-size: 1px">
    <TD><DIV style="margin-left:15px; text-indent:-15px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
        <TD nowrap colspan="2" align="right" style="border-top: 3px double #000000">&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>



<P align="center" style="font-size: 10pt"><!-- Folio -->###<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>v51492v5149200.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 v51492v5149200.gif
M1TE&.#EAT@!&`.8``/S\^<38Y?7Y^>OS]4=LF?+U\OS\_(28MO7X]$YYIKC4
MY?K[^<?1W+3)VC9DF/CXZGF4NJ*HS?GY\(>FQ9BXT:2VR1I4FYVJSJS$V/K\
M_"E:E.7N\/KZ^IVUS'"<P(>AO#EKHW2(J"%*>1M2E&J&JM+BZRE4A_?Z^N3I
M[1I*A5B%LINNT,_<Y=GDZ_'W]Z6\T/OZ^6B-LXR=P/K[]QM-E/S\]_?V\_K[
M]1U1B]SK\&J5N\KAZ_?Z^/KY]O[^_=SH[>?Q]'B-LA=4F_G[^_/X^"-*A9VF
MR_?X^!I8FZ*MT#%>EI:KS??Z]35>B?KZ\]3@YA=5GWN2KEYXFMKBY?CZ\VV!
MGXRPSOOZ]9*JPY"USUY_IOKX^>WV]A99G?K[\+W/W)&AQ/CX]K/"T+&[R?KX
M]?KX\I:FROS^_O;X\OKY^GV?OR9/DR9@GJ"OPAU7D_CY^?W^_AA3EIZ_UNOQ
M\86MS*O`T=3F[9>DN_?W]^#N\OW]_?____S[^_O[\_O\]/[^_B'Y!```````
M+`````#2`$8```?_@`]#0S,/$D=/!S\&<'IZ```^DGI.1!L5%7,&,P!O"!D9
M!H^2``M_IZBIJJNLK:ZOL+&RL[2UMK8`G)!X8@=/)SZGDL,^!GP9)T1C(2@N
M0P!4HHYZI`"WU]C9VMO<VPM]?6$N#%4,)V_$PX\`0V\<>'-W424N-WT`T],`
M-=W]_O\``ZH2X.?*B1)-*A2PT2.?(TB0%NCA,P,-$`(?N/"H@6^:J'T"0XH<
M25(5`@!I6DB)`61(CQH<)1H8LF#&#'M#^)1Q,@1#DP-$(.(S$`IDR:-(DUZ[
M$08%%BT83ESIX42"A`4"B&0]P:.`EU"%X.308D*!'@,`KL`@"E&IV[=P_U/U
M&?(B!H1%]\+<&T*D!0,Q#.:<N)%A"-H%)SH4`?'D#8P>?'R`,A`LKN7+(YFP
M@``FB@M(Q7H80"$FRH'3,L3,X="0#Y\A7QR,R/BFH8\3ABMCWLV;VXDH$&1<
M*"S*!X<!=ZHL6;)BA8P02=)<`?#Q28(12EH<T0/C=N[>X,/;RJ,\2(/70S@L
M&-(F2`4P*Y9?N$!B3)@>,#C8:)'`0HH/`W`0DV%ZB&?@@:UT<,`%!WP1U`)O
M9#!`"&`D$<&%\ZUP01`HE-''$0;PUX4;">R`@`1^0&0`@BRR2,)\,E0@P#XP
M9/`%!/-=&,%\%R1!`@,+7&'8%`G$X88;<A3@A_\?Z^C6XI.]Q3`?&#*XL,`-
M`)S0P((Y8M@C!&,8MB(+!"!A`0X?$`$36I!`Z29O."9A1!!`O.%$EKTLT:6.
M%Z@Q!CJBB&%"%T*,$`,1,`"005MO-AH7!!8F$00+)U!!A980:'B!$49@N()Y
M&QE`Q`<I=`$%$EH`<19-"V3@Z*MNJ;%I!`>8X0("B)7PHAEF],AI$I^R@,8]
M3Q`P0A==Q$%`'GS`0=,0KL(J;4EJ1&J&%"VX<`)N,AR0A!EZ]IB$&FT,<(4$
M>GRPA@7(QB&%JHI2M^*T](8$Z85F0'#'!B<(@``#W6:HH0Q5H(#`#50\(=L(
M2'1A*!=G93!-O10#%(/_A1&8L4(Y1#!1P!$,A!`%&%0&$04#0R#,110T6&"!
M&TC@H,9G>D@L2<4X=Q/"!1$DD<028!R`@E<<'$'$%V8(%X``!N!A0P$-F&`!
M%'$P[,8+05$W<<Y<8]/&`1I>N,(!=^"Q5JM#^-#1-V6$48(#<2`AA,M0)-#"
M$-2HW6;7?->R00AZ=CI?$`P8\,8"3)BBCQ<]S*%&"J?.;0$-6'`!FM[S]JTY
M+"><UD&G1FQ:\`EHH%%#,8_X(<$)%`S:A=Q"Q&'"#X?CH[8!F6^N^RH@0["$
M&3T;D<0!1A!Q\.FBU.`'#"P4*035SQMZPCX<08+[[MBKHH<+6(!]81(7K!#"
M_Q<(X/K&66A0X8(6.)@:>QQ"*%'X%3?TL(^\V>?_1QI#!!#%"A@+7[>><(0,
M<(`/!D"`"UY@`OA!P0(C&($;/``$`UPA)BFBCOZRAX<AS.%K<MJ1&235!B)D
M8`\&$(`+[`""$<`/"4@8`0Z4L(,A)(HH"_`#1PJTP=VA90@_D,(*.!4ZGYG'
M,``0P`!BP#`8QFT$)OB`"X*BAR%LJP\IXF$/-P>#&C!!`'4@0:0P])P-\*$'
M+L!`$9!``R3$86IQT$();)`!'[1*`"?`H@:WN+EUG``((^O2?,BFK0`0`&9Q
M2*0;E8`!)O@!`6O)`!%JL@#[P8%IHC``!P@DL;,L@/\RG[3B`CZ)EL)$1!IZ
ML!\?.&"`5OV!*!(SP`G`4H-[2`.!H\#A0W"'.SZ<91I+DF4L*0,)1_`R;^N0
M6"D(-$IIP)(:TYC,JJ"%NTB@LF;%J<%$'@&'8Q@&@8590#&6F<EBGH`R>AL"
M`X+0*T[QB'`;\`#,W#`""\B-!@?80!=K@#N:H$0G?3"`"]2#.QC,,@TG0.`"
M>+`6'D"H8SS(0$V&((`>7,&A#Z'"#-8R`RK@;3TGT,,5LB*`&4C`"4(:A#N^
M446N4,<F,$"@>HH)`"^LS@4\X"4`;C"#7D+$$1FP24)GP(-9&H`'#L5=80@$
M$9="@@<"X`&K)C(4/N"&)GW_6$!,22D``81BH4BE*E0-,TI(""!MM[-BM[X5
MOBE%@0)-@!D28`9!!Y0`;P#P`RDX@A8G>`$&]9-7#ZBP@#08P+`SV4(:_H!`
M`VAS(MWA#B[/XIH#<F`&3MA$%G6"%:^>`#']<H&V^%"#Q@*`#VD8BBB0"``X
MV)$R7O#"#-*0VO(I2@]^\$(?"N-07[I&&H:M)3]164L]YG5)P?!##U@9"1],
M)`U\$*T`J$"=0?"`$SZ`@S%^2PW72,R7D%6;)!K1"10<0`8`[%7/@D#7-PJA
M4&NH`Q'.R8%%142%1X`!0]3"AS>X((%A\,,#O+">9WB1"O;P@D;]`([KED+`
ML75"_Q_0X`(\SL@+-D@#'E(8A@)+@)]_""4/F)#7!PSXDEK9%M[@`(<_G*4'
M)D8`'HZ0AIC>P`L^,(QVTW9!`)`8$C:)R"RIJJA!+.!TV)Q(9+R0(F30Y,9>
M@`1,%%N#G>@A&4Q(G',!P`,7S(`):%B2I1)L3?N&X0P-`-RL?I:`][[1`G-+
M`0GF@%0>:#>F?$"!`A00`'/P80$N"`"?%4"I-Q1S)E8\@2Y*L0`5'3/(6NUR
M`"8=5"+800$,``(12L!GRZ$RG&A9$CX$L`%!S^$-TJ!.3020`T';@0NH?4F.
M4<D'&,1TEJ04TR`Z"8FEAL*YDS&&'K*,:#[D@L1I>`,1@/\P`#P```8;:(`"
M@'`"#IR!>C-I+.[*2EJ@+FH&_!Q`!4(`P!W%P`W(LD#<"D6`%C#A!I\$[RHK
M4`0<%*$(`9`EF7"`@Q2$@`L<V`(T?<R$-^!A`;5N&@=L78-$B6:4A07`<0B0
M@B;P:RPB(,`4N!""BO^``QS(HQ]X:E@D<H<)#!0!RGQYA>GP@`4Q:$(*4J`!
M+;#@"&$XB1\07$L\O\&AB;*)F%"][7>7PC5"V>E&WS"$+?SYR$0U0`^(T(`$
MV*UH=4B!"+YP!-'`A#HU?C8"%<J!H4PF+7\80@Z"((-.34`)D8N=&RR@A"4(
MP`O\+"9W,M"!N;L!!W1@!P8T`#/_&H1@DF%X0U:80`4)V.`-1SB".]Y@<!L\
M``9A0,.S*%\&`!R!`'%HP@"X,`$-:$`,"CR`!MH-(0$,6`)H`-%"D_$&&\C!
M!#A`F0$`6P88E"`!.-"`U4TP`BW\8KIH*(#R/PR#(^`!`3S@@!,>P`0B#"'Q
M-B@J`IC@!!O,&`]4F8$-;@![I[^APP4(0\X%P!`74``'32A!O^J@`1,$@`QE
MX,"($3`$IUW!"1Q`>>F!!YR`.P\!`VDG`%\@1F9P'5#@!F_V=S&0!PL09:FC
M*/#6`4C`!FQ``PE0`!F@!CC`!EU@>$$A`7D0`%\0&`*&`!N``ALP`%/P!25`
M!`]0`QOP_P,#4``LP``_P`,20`2@IP$#$`!-@`.'P@0S\`(>\`%ST`,H\`,"
M4``,$``;,`02<`,G\`-?,`5RP`8C\`5I4W9.4``3$$$>L`-V$`-0,`)6P`5'
MP`%<^`5Y(`!\0`8%\`.O-@53@`9Y\&I`4(7&@P82,`1`P`)=*!AXP`=S\`,;
M,`<,8%)<D`,,\`4LD`?4QP`BJ`1UP``%$``ZX`$EX`4/X`(_P``,D`->5H8H
MD`-<L`%5.`#0\E.X<U7M$0,N,U?P4R@)\`0GT5S[T`>5P@,=@`,@H`(SQ`)S
MD`!%X`%L8`$AD`P4``)K<&\@0`$N``0JL`8J,`$FD`)LX`$N,/\`!*`!:D`"
M(I`"#H"-7$``4*`$OY<""5`"ET<$+`./L6$!=)``*4`#(,``$@(&2I`"1:`"
M#O,%/$`=K$0F<]4"#]`#+%`$&D`"+C`'!\`&]N8`=#`'-H`!)J`$'O`3.Z`$
M;!`#!"`";J`#+3`#"!``UU$$(I``"C```U`%)J`#"=`$<Y`#:L`&U;@8#9`#
M)D`##U0$!,`"+T`#*:``1)`''J`!U<@&=+`!8*0!;)`%35`$'O@#B\)7A?%M
M+A`#;``_B?1>]O0%!8`&/74_^R``K=(!<9``=`"5+_`%2J`!"J`!0A`"`A``
M'1@#<L`^&I`')Z`%4$0`.C"6%O<&#D#_`VN@!3K@!C1``%S@`@0@!&R@!FT4
M`W/P``7@`E$0!P[P`P'@`!8@?"K@!D40`@/0`$H0EQT``HD4``P52X(RF>Q7
M`'-0!P$P!41P`";`!A.`!;B7!:V9`B-8!&H0`'KI`!\``68B1;]'`UK0`22@
MC@'`!5(0!QUH`GEP!R)@CED``I,)!`<``EU0DG>``DDI`M.6!3A@`EE`!TJ`
M`VUP`G4@-0X0`_V!`Q3P#,64`>YP$R>@`O4T5W`V-R"`EB3&)OB01!&B@2"`
M`=>A`AY@`C*IER3`!4^0!59@!WE``5V``S\P!%K`G27`!1YP)D]@F2-``$"@
MC2.@`5S0CG/3_X&GV082P`/V*`1-0)J-20)`8`?7(04;``$NPY04P$9?H(1X
M<P0O@`,C``*(T@-=AE-".0(ZD`=<H`5N``*<AIP.D`5/L`,:$`=!,(D@(`1:
MD`-9P#`-$&@8>0#:637F,0Y8(`=YD`,Q0`-*L'$>,`(.8`=#P`-B@`/NR0(.
MT`4;F@<Q@`1-D`=U@`-0,`%<H`#/J`/?I%0Q!0,($#5PYD10``4@``$?T**_
M9DQ\0`1XP`$=T`4@$`!J,`)L``)1Y)=Q$`.5R0(34`550``C,@6%B9F--@%4
MLW&@EP#L0`)T%P8"<)E0@`,)H`$CD``NH&Q1``4_6IKX1`4;<*+OHO\%0H`$
M*,`$7T@##(`&/9`30S"I4TH$G(``>0`$+J``*1`'$Z`5$#`B7]``*3`":C``
M!E`"U'H``C`'[ABKS,H&`3`#):`$%B"D)\H&PNJ"7W``5:`%$/NG7#"KV5$1
M8J"4"B`H4/`!4_@!<>">=>`&4-```PL"%J`#=:0/'/$&/\"/3D0HIZD&G](&
M7=5<C\`'`A"'$KH#&)`";B`$#O`%?HD#&VI(*4``4:`#(Y(MXLH&/E`#$^!&
M4^"B"5`#0X"+2G`$)W"9%D``+DD#;L`"B)&M3=!JC7D`5#`'VVFD_<$&*.`%
MYQH`A^-+<,``$,L&0/``9;`!4:`&%>"O-##_`06```=@)&+0`"TC!^?4`J^I
M!KJ9L`$@!1;`L`\P!7#7IEK@@04W`!3@`"(@!1_09@[0`@4``2/0!'8P?2%;
M!`KP`BPK`PA0`!^@E`T@!DE['B4``C@``8S@6@#0!P_``T`PNG(C-Z:B!/?R
M*75P*\[U"$>U!:[ZI260!PT$!5I0A&=*`@,@!5/J(%C`;RB@!R<*`J*PM7'P
M!.U8K5D2`Y@Y1<"*!"P@`!2@EP0P`*#IHS^@`'%[L%H`!3`*`3B`!%\@`'2@
M;EPG<`!`!D=*`R-``<R&!9/S`79@`DB@`ZXXNB#``@W0;]4[L'JI`T#P-FP*
M!%C0,@UP`GY)`P$K_\+JN@/)F@>."G\_X+C@&`"W4@<B:X10$`,#``0Q$)]Y
M@`'HA@$O&P<>4`K5I+QS(`=%,#6$TC!(H`(\LR,R$`0Y(`"/Y0@\D`;;"Z9$
MH`4N@P4NP`(:$+%`P+E2*0>'1*(FRIW0`K\I:BP)0%'VRP8`#*R`G(<J``4:
M\`6@&7J7%K<N\*U"\+]UH`35B@4)\'=B2$S>5YHXX``JH`)OC+8N<`";;`6M
M0\/1IG75"P`$"P4.H`:1Z098@`!D0@.`V:<.$*>CFP`(,+#`Z@!R,`$@X`9*
M8`<"\`%KY`$OL`%"O)0;(`/P1P%TX``X$`5<@`$C``48D`'#&[,UT"IH4?\#
M:&!(UXPLR>(&#C`!/!,Z2Q`%;,QX>I`&<*!5;U`!.$``OY"42M#`++`&-$"^
M8N``6M<$SB@"OZ`%ZN@,$\!O+.`",M?')W"=&D"O%&=Q7H``Z8L#_]9Q3=`"
M"M`$(G``C2P%]7S$4>`&(B`"$'"2#.!0^W`%Z_$""?"-_`8"#8``8?`#27QO
M)J`"=H`&#7#2=8`K!.NC,I<",=`"Y5,'("`")B`"#O`"`T`$4A"U@\`%'Z`$
M)YT`YP:/&=``%)=Q3S`&6J<`"X`"9''2-_D#1%`'_-P`0Z"H-``!W1P*>D`&
M`Q`%.#`YR!)#YQP$0\0IS7$RVQ<&HC`#(,<"5O#_`BVQ`5F@V`B``A=@!0U`
M!"Z0`Q0@!SN0!SL0``6@):3L4`%``5FP`2Y0`5:``07``PU`RIW]`E;0`05@
M"):=!>7R!8T]`#\@V@R@0AB0!6+0N`.@`'(0``-0`CLP`#\&$U4T!,&=!5F@
M`(3)!'1TJ7)``2GJ`E30`DO0`260."700&JP`Q2@`%19$5O8VT%Y5B<@!EF`
M`4>0?5P0`.V=`RF8G8CQ`W+@VW/P!%:0!3]`!@``!#N0!9@-P">@W58P!3>`
M`AU`!PW`5\;``1405Y,C!"-RR!MP&BNP(Q>P!,^Q@\]R!6F@!P)0F47AEK7&
M!T<PA3QP'TPW`VU3!C>(_P#S)0$NG154D'A:414(4)DUT`/;\@8W8&)D<`)<
M<`XJU#0D90#=MP5X9`.`-@`"P'19,019]E,^P`>*M2TG4``],+0"5QA$P`$%
M@&J;U`Y.0`4/:P$>P`59`5VHMEQ3M`4(@!OG,TLVH#H/((R5A'\PX'0V(5I#
M$(<5=F0U0`01D@$"``-.\^4GX`0[D0'.@&2/T`*R,:[L$I\O<`1#\`0A@`4A
M%#X04"Y-,P2-8`RX4W96\>=G`0!.X`<SX$OI@>IZP`'.8`QW8FL`(`$]T&@9
M0!75XP35PP=4\.-DD$*8105,`%TW@0:N[@2JI`>-!@!EX`5E8`![8&2VLWMI
M8?]3>RX!,P#F?#!]3$8=0FX5$K#G+&`"17``:#!@$T$3A@!F_/0:1R;L,V$,
M5L0!Y)4&6[``.W$#/,41*>/25U9C$N`%=V)LD'`#'%$##Y!%CV`#4;`N]L0N
M&L`2_PX$"PCJGO(C[_99O-0#,[``83#!G<`7([8>C89:M-5*-9(3^K>(%$$%
MMH851P!Q#M],GCKE:R$`:LD5OK3B.35*3&!+,%#RNQ=O@X`WCJ!5(4<$/.`8
M)\]3"\=E6>$:5VY'6;@!2X`%#%`&/9`X,]#K-P`#>)3SEZ7L5W4X_),6G7`"
MB=<.-S0(2E@_W9$3DL=0($<3MR$`ZN$$)B\=/&"$N3C_-]1)*6F`%:6],SIB
M!N>U`9\P4]4D[1-1#%])%)5_0.!E38W0#A/Q2<9$(.HA$YUD1:MEY=M&&?EN
M@(N228Z@7;3>2<:D2<@0"KZD-]-@177T9XS@8BZ]`%I1@+L$&J#@"`R_'G1=
MZWB3*"S_2Y(`3L]@3-D%5)^U`*RT(LA0'+7.`5>`L"W3,`]$``SP6T0Q!%:]
M()W2'!!0`2Y@;#7`":XU#'RT.?UG`Q4@`D[T/#@`"!@N/0``!AD9)QLA,BL7
M%TE@)'EP'``S`'\^FSY_GI^@H:*CI*6FIZBIJJNLK:T9'`P.%EUN<7$:6%P(
M3A(`B`8&'"Q1$TL1$4DR!P5#_PN%FIRNT]35UM?8UT-`06NT<18X.C\N5+V_
M&08`'`,-(4N022LA#"=#A9QZ>MG\_?[_`$,-J>-@A`4A7480L"-@@1,GAM(9
MT'/D!)`*(<PD27(!3!070PPL\*%/7\"3*%.J#.4BP0@A%I#$`=&`")Q"A@Z5
M-#"#QP`P,LP\NA"DP1L]`$B67,FTJ5-J7U)T$1)GA`8*7&9P(AE,G[`:5P"@
MJ*+1",<H*)QQ@@/GJ=NW<$$%P8&D"Y(B2P;@,1#-!UNV>H8060`#1H86),!<
M,#*/P1L^$_6PC4NYLDJ7WU1LD%`&1C!UA?0<&L)D`1_()]I$N;!B11#'HG=:
MGDV;G_\4@UTT-$`CP<F0DK%++F`2C,^,&7-DR%CBFD'(R")K2Y_>Z@,.F"H&
M//!R@R\I/:6#U>BCYTN4%4OHX8$CG`?U]_!)!;@^0LX))WX`[/N>4YT3`RU$
MP=P!*!P!'``+Q*>@@D>H,`(."@APACHUG*+430)L@$5C;^S%270+ACB=`0$0
M($*$D(U4"E)P()+!&Q9AH<8=>)SPQE:BB:@C;7JX4($(<KC`!P!A9+!B#0`,
M,<0))Q#Q1!4A3!%229ODN..5<7&PP`!U$#`%##T)L*(?/=DSQ!L52)&6'I!-
MI(E)6,;YE"5'S-$&"V`B(.9W9#+!`P]#X#%&/27!X4-DF\A3J2A3;URQP!`N
MO+$%@B>L6,B?"^BQ!1Z0>78H3GHDNNBH)[5X#P`P\,%!&GN.XM62"]C0@PUD
?>*H')J&)2NJN_0#G*Q\K^AJ;`23YY:NNO"9K32``.S\_
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
